THE PHAGE
Blood-glucose foundation model and personalized glucose management for preventive care
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
THE PHAGE, Inc. (株式会社ザ・ファージ) is a Japan-based health AI company developing CGFM, a blood-glucose foundation model trained on continuous glucose data, and Glucose Flight, a service that helps people manage meals and lifestyle using predicted postprandial glucose responses. It works with hospitals, clinics, corporate health insurers and local governments, and has run large CGM demonstration programs. In October 2026 it announced ¥570 million through a Series A 1st round and loans led by Itochu Technology Ventures, with Tokio Marine & Nichido Fire Insurance and Fukui Capital Partners joining, plus a capital and business alliance with Tokio Marine Holdings.
- Website
- thephage.life
- Stage
- series-a
- Location
- Japan
- Added via
- web
- Ownership
- unclaimed